Puromycin Antibody (Rabbit mAb) [H12G14]

Catalog No.: F6534

    Application: Reactivity:
    • Lane 1: Hela, Lane 2: Hela (Puromycin, 1uM, 30 min), Lane 3: NIH/3T3, Lane 4: NIH/3T3 Hela (Puromycin, 1uM, 30 min)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%
    転写条件(ウェット): 250 mA, 180 min

    使用情報

    Dilution
    1:1000
    1:30
    1:5000
    1:500
    1:500
    Application
    WB, IP, IHC, IF, FCM
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Chemical
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    ポジティブコントロール HeLa cells (Puromycin, 1uM, 30 min); NIH/3T3 cells (Puromycin, 1uM, 30 min); C6 cells (Puromycin, 1uM, 30 min)
    ネガティブコントロール Rat kidney tissue; Mouse kidney tissue; Human kidney tissue; NIH/3T3 cells; C6 cells; HeLa cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. Reference Table for Selecting PVDF Membrane Pore Size Specifications
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Puromycin Antibody (Rabbit mAb) [H12G14] detects exogenous levels of total Puromycin.
    Clone
    H12G14
    Synonym(s)
    Puromycin-sensitive aminopeptidase, PSA, Cytosol alanyl aminopeptidase (AAP-S), NPEPPS, PSA
    Background
    Puromycin is a naturally occurring aminonucleoside antibiotic derived from Streptomyces alboniger that functions as a small‑molecule mimic of the 3′ end of aminoacyl‑tRNA and acts as a potent, universal inhibitor of translation by directly engaging the ribosomal elongation machinery in both prokaryotic and eukaryotic cells. The molecule consists of an adenosine‑like nucleoside covalently linked through its ribose 3′ position to a tyrosine‑like amino acid moiety, creating a structural analog of the 3′‑CCA terminus of charged tRNA in which the natural ester linkage between tRNA and amino acid is replaced with a non‑hydrolyzable amide bond that resists peptidyl‑tRNA hydrolysis and underlies its chain‑terminating activity. Puromycin enters the ribosomal A site in competition with aminoacyl‑tRNA, aligns its amino group in the peptidyl transferase center, and accepts the growing polypeptide from the P‑site peptidyl‑tRNA to form a peptidyl‑puromycin conjugate; the resulting product lacks a tRNA moiety and fails to remain stably anchored in the ribosome, leading to dissociation of the truncated peptidyl‑puromycin from the P‑site and premature termination of protein synthesis while leaving the ribosome as an intact 70S (or 80S) monosome that can fall off mRNA as a single particle rather than dissociating into subunits as in normal termination. This mechanism places puromycin as an elongation‑stage inhibitor that does not require specific initiation context, allowing incorporation into nascent chains on any actively translating ribosome and generating a population of puromycylated nascent chains that carry the antibiotic covalently at their C‑terminus, a property exploited extensively in molecular biology to label and quantify nascent protein synthesis in approaches such as SUnSET and ribosome profiling–derived puromycylation assays. Puromycin’s ribosome‑catalyzed incorporation follows the same chemistry as peptidyl transfer between two tRNAs, and its effectiveness arises from the conserved architecture of the peptidyl transferase center and A‑site across bacteria and eukaryotes, which permits broad‑spectrum inhibition despite differences in ribosomal protein composition. The antibiotic blocks further elongation cycles by occupying the A site and by removing the growing chain from its tRNA carrier, so subsequent EF‑Tu/eEF1A‑dependent aminoacyl‑tRNA delivery is futile, global translation drops rapidly, and cells experience proteostasis stress that activates integrated stress responses, unfolded protein responses, and, at higher concentrations or prolonged exposure, apoptotic and necrotic pathways. Puromycin is also used as a powerful selection reagent in mammalian cell culture, where co‑expression of the bacterial puromycin N‑acetyl‑transferase (pac) gene confers resistance by enzymatic acetylation of the amino group on puromycin, preventing its participation in peptidyl transfer and allowing survival of transfected cells under continuous antibiotic pressure.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください